Guardant Health: Barclays raises target price to $220 from $200
GH•Barclays raised its target price for Guardant Health to $220 from $200.
Related News
BridgeBio Pharma: Barclays cuts target price to $156 from $157
BBIO•
Vertical Aerospace unit filed patent infringement counterclaim against Archer Aviation
ACHR•
Marvell Technology raises target price to $300 from $268
MRVL•
Most US voters reportedly say Trump, Congress don't take AI risks seriously
QQQ•
Gogoro sells 24,936,057 unregistered shares in $61.8 million private placement
GGR•